Antiphospholipid Antibodies in Patients with Type 2 Diabetes Mellitus
Patients with diabetes mellitus type 2 have a greater risk of accelerated atherosclerosis. Antiphospholipid antibodies(aPL)are associated with greater risk for thrombosis. To demonstrate the possible role of anticardiolipin(aCL) and anti-β2 glycoprotein(β2 GP1) antibodies in such patients, we invest...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Mosul
2020-01-01
|
Series: | Annals of the College of Medicine Mosul |
Subjects: | |
Online Access: | https://mmed.mosuljournals.com/article_164151_f6061cf8f85c04d2a5acf6d4cc9f1c8c.pdf |